Janus Henderson Group PLC Decibel Therapeutics, Inc. Transaction History

Janus Henderson Group PLC

  • $182 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 16, 2021
SELL
$6.6 - $9.04 $4.51 Million - $6.17 Million
-682,597 Closed
0 $0
Q2 2021

Aug 16, 2021
SELL
$6.39 - $11.51 $72,775 - $131,087
-11,389 Reduced 1.64%
682,597 $5.75 Million
Q1 2021

May 17, 2021
BUY
$10.56 - $19.9 $7.33 Million - $13.8 Million
693,986 New
693,986 $7.54 Million

About Decibel Therapeutics, Inc.

DBTX Quotes by TradingView
  • Ticker DBTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 24,964,500
  • Description
  • Decibel Therapeutics, Inc., a clinical-stage biotechnology company, engages in discovering and developing transformative treatments for hearing and balance disorders. Its product candidates and programs focuses on three areas, such as Gene Therapies for Congenital, Monogenic Hearing Loss designed to restore functional cells within the cochlea to...
More about DBTX
Track This Portfolio

Track Janus Henderson Group PLC Portfolio

Follow Janus Henderson Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email